Essliver forte caps. # 50
Dosage:
300 mg
300mg
phospholipids (essential phospholipids) (containing phosphatidylcholine 29%, phosphatidylethanolamine, etc.) 300 mg, thiamine mononitrate 6 mg, riboflavin 6 mg, pyridoxine hydrochloride 6 mg, alpha-tocopherol acetate (in the form of a semi-finished product 50%: alpha-tocopherol acetate
Category
Preparations for the gastrointestinal tract
Scope of the drug
Gastrointestinal tract
Manufacturer country
India
Minimum age from
12 years
Way of introduction
Through the mouth
Pharmaco-therapeutic group
N4
Name ENG
ESSLIVER FORTE
Clinical and pharmacological group
Hepatoprotector
ATX code
Combination of drugs for the treatment of liver and biliary tract diseases
Dosage
300 mg
Indications
Fatty degeneration of the liver of various etiologies, disorders of liver lipid metabolism
hepatitis, liver cirrhosis
toxic liver damage (alcoholic, narcotic, medicinal)
radiation syndrome
psoriasis (as part of combination therapy).
INN / Active ingredient
Multivitamins + Phospholipids
Contraindications
Hypersensitivity to the components of the drug, children under 12 years of age.
Use with caution during pregnancy, lactation.
Specifications
Category
Preparations for the gastrointestinal tract
Scope of the drug
Gastrointestinal tract
Manufacturer country
India
Minimum age from
12 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Stada
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Hepatoprotective agent
Dosage form
Capsules
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
300 mg
Package weight, g
fifty
Anatomical and therapeutic characteristics
:
A05C Drugs for the treatment of liver and biliary tract diseases in combination